HRMY
Harmony Biosciences Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$42.25
+0.93%Margins
Gross margin
75.4%
EBITDA margin
28.8%
EBIT margin
24.0%
Net margin
18.9%
FCF margin
37.0%
18.1%
Return on equity
13.2%
Return on assets
20.0%
Return on invested capital
0.73x
Asset turnover
$355.1M
Cash from operations
$11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026